These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 478308)

  • 61. Another swing of the pendulum.
    Walsh AC
    J Am Geriatr Soc; 1990 Oct; 38(10):1162-3. PubMed ID: 2229873
    [No Abstract]   [Full Text] [Related]  

  • 62. [Dementia: progress in diagnosis and treatment; Topics, III. Treatments; 2. Pharmacological treatment of dementia].
    Nagata K; Takano D; Yamazaki T; Maeda T; Satoh Y; Nakase T
    Nihon Naika Gakkai Zasshi; 2011 Aug; 100(8):2134-45. PubMed ID: 21899144
    [No Abstract]   [Full Text] [Related]  

  • 63. What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?
    Wimo A
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):1-4. PubMed ID: 33241968
    [No Abstract]   [Full Text] [Related]  

  • 64. Imagining a Role for Psychedelics in Dementia Care.
    George DR; Hanson R
    Am J Geriatr Psychiatry; 2019 Sep; 27(9):1028-1030. PubMed ID: 31047789
    [No Abstract]   [Full Text] [Related]  

  • 65. Desferrioxamine and Alzheimer's dementia.
    King RG
    Med J Aust; 1985 Mar; 142(6):352. PubMed ID: 4038776
    [No Abstract]   [Full Text] [Related]  

  • 66. Opportunities for and obstacles to treatments for dementias.
    Yesavage JA
    J Am Geriatr Soc; 1983 Jan; 31(1):59-60. PubMed ID: 6848578
    [No Abstract]   [Full Text] [Related]  

  • 67. Neuropeptides and dementia.
    Kragh-Sørensen PK; Lolk A
    Prog Brain Res; 1987; 72():269-77. PubMed ID: 3303129
    [No Abstract]   [Full Text] [Related]  

  • 68. Pharmacotherapy of senile dementia.
    Reisberg B; Ferris SH; Gershon S
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():233-64. PubMed ID: 6997869
    [No Abstract]   [Full Text] [Related]  

  • 69. Lack of efficacy of hydergine in Alzheimer's disease.
    Posner JD; Landsberg L
    N Engl J Med; 1991 Jan; 324(3):197-8. PubMed ID: 1984200
    [No Abstract]   [Full Text] [Related]  

  • 70. The effects of Hydergine on neurotransmitters.
    Ermini M
    Br J Clin Pract Suppl; 1985 Jun; 39():11-5. PubMed ID: 2864053
    [No Abstract]   [Full Text] [Related]  

  • 71. Ergots in the treatment of mental disorders of old age.
    Gaitz CM; Hartford JT
    Adv Biochem Psychopharmacol; 1980; 23():349-56. PubMed ID: 7395621
    [No Abstract]   [Full Text] [Related]  

  • 72. Hydergine in Alzheimer's disease.
    Baer L; Jenike MA
    J Geriatr Psychiatry Neurol; 1991; 4(2):122-3. PubMed ID: 1854422
    [No Abstract]   [Full Text] [Related]  

  • 73. [Are the so-called cerebroactive drugs really useful?].
    Reubi F
    Ther Umsch; 1985 Aug; 42(8):547-51. PubMed ID: 4049306
    [No Abstract]   [Full Text] [Related]  

  • 74. Hydergine helpful for Alzheimer's disease.
    Geriatrics; 1979 Oct; 34(10):23. PubMed ID: 478308
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.